Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1992 Feb;82(2):236–242. doi: 10.2105/ajph.82.2.236

Attitudes toward genetic testing of Amish, Mennonite, and Hutterite families with cystic fibrosis.

S R Miller 1, R H Schwartz 1
PMCID: PMC1694304  PMID: 1739154

Abstract

BACKGROUND. We had the unique opportunity to study families with cystic fibrosis (CF) from an interrelated Amish-Mennonite kindred and from an isolated Hutterite kindred. METHODS. While obtaining blood for DNA linkage analysis to help find the CF gene, we asked family members to answer a questionnaire about attitudes and feelings toward genetic testing. The questionnaire was also administered to families receiving care at the University of Rochester. After DNA-based CF carrier testing was developed, we asked the families whether they wanted to know the results. RESULTS. Each cultural group felt differently about many issues. Between 31% and 78% approved of CF-carrier testing and 14% to 78% approved of prenatal diagnosis. The majority (59%) of Hutterite parents and siblings were opposed to carriers marrying carriers and most (82%) of the CF families wanted to know the results of carrier testing. CONCLUSIONS. Cultural differences need to be understood before genetic services are offered. Also, most CF mutations and their clinical correlates (phenotypes) will need to be defined. There are as few as three CF mutations in the Hutterite population. It will be possible to offer them the option to choose accurate genetic counseling. It will be difficult to offer genetic services to other populations with more heterogeneous attitudes and many more identified and yet-to-be-identified CF mutations.

Full text

PDF
236

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaudet A. L. Carrier screening for cystic fibrosis. Am J Hum Genet. 1990 Oct;47(4):603–605. [PMC free article] [PubMed] [Google Scholar]
  2. Campbell P. W., 3rd, Phillips J. A., 3rd, Krishnamani M. R., Maness K. J., Hazinski T. A. Cystic fibrosis: relationship between clinical status and F508 deletion. J Pediatr. 1991 Feb;118(2):239–241. doi: 10.1016/s0022-3476(05)80490-1. [DOI] [PubMed] [Google Scholar]
  3. Cutting G. R., Antonarakis S. E., Buetow K. H., Kasch L. M., Rosenstein B. J., Kazazian H. H., Jr Analysis of DNA polymorphism haplotypes linked to the cystic fibrosis locus in North American black and Caucasian families supports the existence of multiple mutations of the cystic fibrosis gene. Am J Hum Genet. 1989 Mar;44(3):307–318. [PMC free article] [PubMed] [Google Scholar]
  4. Fujiwara T. M., Morgan K., Schwartz R. H., Doherty R. A., Miller S. R., Klinger K., Stanislovitis P., Stuart N., Watkins P. C. Genealogical analysis of cystic fibrosis families and chromosome 7q RFLP haplotypes in the Hutterite Brethren. Am J Hum Genet. 1989 Mar;44(3):327–337. [PMC free article] [PubMed] [Google Scholar]
  5. Kerem B. S., Buchanan J. A., Durie P., Corey M. L., Levison H., Rommens J. M., Buchwald M., Tsui L. C. DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet. 1989 Jun;44(6):827–834. [PMC free article] [PubMed] [Google Scholar]
  6. Kerem B., Rommens J. M., Buchanan J. A., Markiewicz D., Cox T. K., Chakravarti A., Buchwald M., Tsui L. C. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989 Sep 8;245(4922):1073–1080. doi: 10.1126/science.2570460. [DOI] [PubMed] [Google Scholar]
  7. Klinger K., Horn G. T., Stanislovitis P., Schwartz R. H., Fujiwara T. M., Morgan K. Cystic fibrosis mutations in the Hutterite Brethren. Am J Hum Genet. 1990 May;46(5):983–987. [PMC free article] [PubMed] [Google Scholar]
  8. Klinger K., Stanislovitis P., Hoffman N., Watkins P. C., Schwartz R., Doherty R., Scambler P., Farrall M., Williamson R., Wainwright B. Genetic homogeneity of cystic fibrosis. Nucleic Acids Res. 1986 Nov 11;14(21):8681–8686. doi: 10.1093/nar/14.21.8681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
  10. Rommens J. M., Iannuzzi M. C., Kerem B., Drumm M. L., Melmer G., Dean M., Rozmahel R., Cole J. L., Kennedy D., Hidaka N. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 Sep 8;245(4922):1059–1065. doi: 10.1126/science.2772657. [DOI] [PubMed] [Google Scholar]
  11. Rozen R., Schwartz R. H., Hilman B. C., Stanislovitis P., Horn G. T., Klinger K., Daigneault J., De Braekeleer M., Kerem B., Tsui L. Cystic fibrosis mutations in North American populations of French ancestry: analysis of Quebec French-Canadian and Louisiana Acadian families. Am J Hum Genet. 1990 Oct;47(4):606–610. [PMC free article] [PubMed] [Google Scholar]
  12. Watkins P. C., Schwartz R., Hoffman N., Stanislovitis P., Doherty R., Klinger K. A linkage study of cystic fibrosis in extended multigenerational pedigrees. Am J Hum Genet. 1986 Dec;39(6):735–743. [PMC free article] [PubMed] [Google Scholar]
  13. Wilfond Benjamin S., Fost Norman. The cystic fibrosis gene: medical and social implications for heterozygote detection. JAMA. 1990 May 23;263(10):2777–2783. [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES